Abstract: A novel maize variety designated X85R242 and seed, plants and plant parts thereof are produced by crossing inbred maize varieties. Methods for producing a maize plant by crossing hybrid maize variety X85R242 with another maize plant are disclosed. Methods for producing a maize plant containing in its genetic material one or more traits introgressed into X85R242 through backcrossing or genetic transformation, and to the maize seed, plant and plant part produced thereby are described. Maize variety X85R242, the seed, the plant produced from the seed, and variants, mutants, and minor modifications of maize variety X85R242 are provided. Methods for producing maize varieties derived from maize variety X85R242 and methods of using maize variety X85R242 are disclosed.

Abstract: The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.

Abstract: The invention provides antibodies that specifically bind sortilin. The antibodies inhibit or delay pathologies associated with changes in progranulin levels and associated symptomatic deterioration.

Abstract: The invention provides antibodies that specifically bind sortilin. The antibodies inhibit or delay pathologies associated with changes in progranulin levels and associated symptomatic deterioration.

Abstract: A novel maize variety designated 1PHMT48 and seed, plants and plant parts thereof are provided. Methods for producing a maize plant comprise crossing maize variety 1PHMT48 with another maize plant are provided. Methods for producing a maize plant containing in its genetic material one or more traits introgressed into 1PHMT48 through backcross conversion and/or transformation, and to the maize seed, plant and plant part produced thereby are provided. Hybrid maize seed, plants or plant parts are produced by crossing the variety 1PHMT48 or a locus conversion of 1PHMT48 with another maize variety.

Abstract: The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.

Abstract: The invention provides methods of treating taupathies such as Alzheimer's disease with antibodies that bind to human tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.

Abstract: A novel maize variety designated X90V907 and seed, plants and plant parts thereof are produced by crossing inbred maize varieties. Methods for producing a maize plant by crossing hybrid maize variety X90V907 with another maize plant are disclosed. Methods for producing a maize plant containing in its genetic material one or more traits introgressed into X90V907 through backcrossing or genetic transformation, and to the maize seed, plant and plant part produced thereby are described. Maize variety X90V907, the seed, the plant produced from the seed, and variants, mutants, and minor modifications of maize variety X90V907 are provided. Methods for producing maize varieties derived from maize variety X90V907 and methods of using maize variety X90V907 are disclosed.

Abstract: A novel maize variety designated X80V618 and seed, plants and plant parts thereof are produced by crossing inbred maize varieties. Methods for producing a maize plant by crossing hybrid maize variety X80V618 with another maize plant are disclosed. Methods for producing a maize plant containing in its genetic material one or more traits introgressed into X80V618 through backcrossing or genetic transformation, and to the maize seed, plant and plant part produced thereby are described. Maize variety X80V618, the seed, the plant produced from the seed, and variants, mutants, and minor modifications of maize variety X80V618 are provided. Methods for producing maize varieties derived from maize variety X80V618 and methods of using maize variety X80V618 are disclosed.

Abstract: The invention provides antibodies that specifically bind sortilin. The antibodies inhibit or delay pathologies associated with changes in progranulin levels and associated symptomatic deterioration.

Abstract: The invention provides antibodies to tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.

Abstract: The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.

Abstract: The invention provides antibodies that specifically bind sortilin. The antibodies inhibit or delay pathologies associated with changes in progranulin levels and associated symptomatic deterioration.

Abstract: A novel maize variety designated X85P966 and seed, plants and plant parts thereof are produced by crossing inbred maize varieties. Methods for producing a maize plant by crossing hybrid maize variety X85P966 with another maize plant are disclosed. Methods for producing a maize plant containing in its genetic material one or more traits introgressed into X85P966 through backcrossing or genetic transformation, and to the maize seed, plant and plant part produced thereby are described. Maize variety X85P966, the seed, the plant produced from the seed, and variants, mutants, and minor modifications of maize variety X85P966 are provided. Methods for producing maize varieties derived from maize variety X85P966 and methods of using maize variety X85P966 are disclosed.

Abstract: A novel maize variety designated 1PFKS71 and seed, plants and plant parts thereof are provided. Methods for producing a maize plant comprise crossing maize variety 1PFKS71 with another maize plant are provided. Methods for producing a maize plant containing in its genetic material one or more traits introgressed into 1PFKS71 through backcross conversion and/or transformation, and to the maize seed, plant and plant part produced thereby are provided. Hybrid maize seed, plants or plant parts are produced by crossing the variety 1PFKS71 or a locus conversion of 1PFKS71 with another maize variety.

Abstract: A novel maize variety designated X90P473 and seed, plants and plant parts thereof are produced by crossing inbred maize varieties. Methods for producing a maize plant by crossing hybrid maize variety X90P473 with another maize plant are disclosed. Methods for producing a maize plant containing in its genetic material one or more traits introgressed into X90P473 through backcrossing or genetic transformation, and to the maize seed, plant and plant part produced thereby are described. Maize variety X90P473, the seed, the plant produced from the seed, and variants, mutants, and minor modifications of maize variety X90P473 are provided. Methods for producing maize varieties derived from maize variety X90P473 and methods of using maize variety X90P473 are disclosed.

Abstract: The invention provides antibodies to tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.

Abstract: A novel maize variety designated 1PQCD72 and seed, plants and plant parts thereof are provided. Methods for producing a maize plant comprise crossing maize variety 1PQCD72 with another maize plant are provided. Methods for producing a maize plant containing in its genetic material one or more traits introgressed into 1PQCD72 through backcross conversion and/or transformation, and to the maize seed, plant and plant part produced thereby are provided. Hybrid maize seed, plants or plant parts are produced by crossing the variety 1PQCD72 or a locus conversion of 1PQCD72 with another maize variety.

Abstract: The invention provides antibodies to tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.

Abstract: According to aspects of this disclosure, systems and methods for spectrum sharing comprising is presented. The system comprises at least one controller configured to receive first data pertaining to a first system, and send to and receive second data from a second system, the first system and second system configured to use at least part of the same spectrum, the at least one controller being further configured to based at least in part on the first data, determine that the first system is using at least part of the same spectrum based at least in part of the second data, determine that the first system is likely to be interfered with by the second system, and provide instructions instructing the second system to modify one or more operational parameters of the second system to reduce interference with the first system.